对药理学替代品的评估,以减少电射产生的疼痛和不适,在公羊的雄羊
Mariana Karla Francolino da Silva1,2, Leonardo de Almeida Gélio2, Eunice Oba3
1Department of Animal Reproduction (VRA), São Paulo University (USP), São Paulo, São Paulo, Brazil.
Reproduction in domestic animals = Zuchthygiene
|January 25, 2024
概括
雄羊的电射 (EE) 会引起不适. 结合利多卡因化和芬太尼酸盐用于局部麻醉阻塞,显著降低了动脉阻塞,表明精液采集期间的压力较小.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 动物繁殖 动物繁殖
- 麻醉学 麻醉学
背景情况:
- 电射精 (EE) 是动物精液采集的主要方法.
- EE可以引起显著的不适,由肌肉收缩,发声和动力衰竭证明.
- 在EE期间尽量减少压力对于动物福利至关重要.
研究的目的:
- 评估局部麻醉阻塞协议,以减少拉姆斯的EE相关不适.
- 为了比较两个解剖学接入点用于麻醉无敏化.
- 为了评估单独使用利多卡因化与联合使用芬太尼酸盐的疗效.
主要方法:
- 在一项研究中,使用了四只多珀公羊,并进行了五次精液采集处理.
- 治疗包括常规的EE (控制),用利多卡因进行腹腔阻塞,用利多卡因和芬太尼进行腹腔阻塞,用利多卡因进行围接入,用利多卡因和芬太尼进行围接入.
- 评估了精液质量,生理参数 (血压,心率,呼吸率) 和压力指标 (皮质醇,肌酸激酶,发声,).
主要成果:
- 没有观察到血压,精子运动,活力,肌酸酶或皮质醇水平的显著差异.
- 发音显示了个体变化,但没有群体差异.
- 使用利多卡因和芬太尼结合的阻塞药物显著降低了EE期间无氧发生率.
结论:
- 芬太尼酸盐和利多卡因化的组合有效地减少了雄羊EE期间的不适.
- 这种麻醉方法改善了动物福利,而不管选择的解剖进入封锁.
- 进一步的研究可能会探索最佳剂量和长期影响.
相关概念视频
Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...


